Cover Image
市場調查報告書

腎上腺素注射器的全球市場:2015年∼2019年

Global Epinephrine Autoinjector Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 282669
出版日期 內容資訊 英文 89 Pages
訂單完成後即時交付
價格
Back to Top
腎上腺素注射器的全球市場:2015年∼2019年 Global Epinephrine Autoinjector Market 2015-2019
出版日期: 2015年03月25日 內容資訊: 英文 89 Pages
簡介

腎上腺素注射器的全球市場,從2014年到2019年,預計以13.12%的年複合成長率擴大。

本報告提供全球腎上腺素注射器市場現狀及今後的預測、市場促進及阻礙因素與其影響力、主要企業簡介、今後的市場機會等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 腎上腺素注射器概要

第7章 市場概要

第8章 影響腎上腺素注射器發展的主要原因

第9章 市場形勢

  • 市場規模與預測
  • 腎上腺素注射器的美國市場
    • 市場規模與預測
  • 波特的五力分析

第10章 地理區分

  • 腎上腺素注射器的全球市場

第11章 罹患率和盛行率

第12章 腎上腺素注射器的競爭情形

第13章 產品說明

  • EpiPen
  • Jext
  • Adrenaclick
  • Anapen
  • Auvi-Q

第14章 產品形勢

第15章 購買標準

第16章 市場成長因素

第17章 成長因素與其影響

第18章 市場課題

第19章 成長因素與課題的影響

第20章 市場趨勢

第21章 趨勢與其影響

第22章 業者情勢

  • 競爭模式
    • 主要消息
    • M&A
  • 市場佔有率分析
    • ALK-Abello
    • Amedra Pharmaceuticals
    • Lincoln Medical
    • Mylan
    • Sanofi
  • 其他卓越供應商

第23章 主要供應商分析

  • ALK-Abello
  • Amedra Pharmaceuticals
  • Lincoln Medical
  • Mylan
  • Sanofi SA

第24章 相關報告

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR5520

About Epinephrine

Epinephrine, commonly known as adrenaline, is a hormone secreted by the medulla of the adrenal gland and circulated through the bloodstream. It acts as a neurotransmitter that responds to brain signals. These signals trigger responses such as threat, excitement, danger, emotion, and stress, which stimulate the adrenal gland to secrete epinephrine in response to the changes in the body. Adrenaline prepares the body to fight against anaphylactic shock that occurs due to allergic reactions, cardiac arrest, asthma, and superficial bleeding. Chemically synthesized epinephrine is usually administered to patients suffering from the above symptoms because it stimulates the heartbeat, increases blood pressure, relaxes involuntary muscles, and constricts small blood vessels. Epinephrine is also used with local anesthetic agents such as bupivacaine and lidocaine to enhance the effect of anesthesia. It is available in injection form as well as aerosol form for inhalation.

Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.

TechNavio's analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.12 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Epinephrine Auto-injector market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various epinephrine auto-injectors that are available in the market.

TechNavio's report, Global Epinephrine Auto-injector Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • ALK Abello
  • Amedra Pharmaceuticals
  • Lincoln Medical
  • Mylan
  • Sanofi

Other Prominent Vendors

  • Adamis Pharmaceuticals
  • Antares Pharma
  • Hospira
  • Intelliject
  • Teva Pharmaceutical Industries

Market Driver

  • Increased Prevalence of Allergies
  • For a full, detailed list, view our report

Market Challenge

  • Adverse Side Effects
  • For a full, detailed list, view our report

Market Trend

  • Development of CFC-free Epinephrine Auto-injectors
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview: Epinephrine Autoinjector

07. Market Overview

08. Key Factors Influencing Development of Epinephrine Autoinjectors

09. Market Landscape

  • 09.1. Market Size and Forecast
  • 09.2. Epinephrine Autoinjector Market in US

Market Size and Forecast

  • 09.3. Five Forces Analysis

10. Geographical Segmentation

  • 10.1. Global Epinephrine Autoinjector Market by Geographical Segmentation 2014-2019

11. Rate of Incidence and Prevalence

12. Competitive Landscape of Epinephrine Autoinjectors

13. Product Description

    • 13.1.1. EpiPen
    • 13.1.2. Jext
    • 13.1.3. Adrenaclick
    • 13.1.4. Anapen
    • 13.1.5. Auvi-Q

14. Product Landscape

15. Buying Criteria

16. Market Growth Drivers

17. Drivers and their Impact

18. Market Challenges

19. Impact of Drivers and Challenges

20. Market Trends

21. Trends and their Impact

22. Vendor Landscape

  • 22.1. Competitive Scenario
    • 22.1.1. Key News
    • 22.1.2. Mergers and Acquisitions
  • 22.2. Market Share Analysis 2014
    • 22.2.1. ALK-Abello
    • 22.2.2. Amedra Pharmaceuticals
    • 22.2.3. Lincoln Medical
    • 22.2.4. Mylan
    • 22.2.5. Sanofi
  • 22.3. Other Prominent Vendors

23. Key Vendor Analysis

  • 23.1. ALK-Abello
    • 23.1.1. Key Facts
    • 23.1.2. Business Overview
    • 23.1.3. Product Segmentation by Revenue 2014
    • 23.1.4. Product Segmentation by Revenue 2013 and 2014
    • 23.1.5. Geographical Segmentation by Revenue 2014
    • 23.1.6. Business Strategy
    • 23.1.7. Recent Developments
    • 23.1.8. SWOT Analysis
  • 23.2. Amedra Pharmaceuticals
    • 23.2.1. Key Facts
    • 23.2.2. Business Overview
    • 23.2.3. SWOT Analysis
  • 23.3. Lincoln Medical
    • 23.3.1. Key Facts
    • 23.3.2. Business Overview
    • 23.3.3. Geographical Presence
    • 23.3.4. Recent Developments
    • 23.3.5. SWOT Analysis
  • 23.4. Mylan
    • 23.4.1. Key Facts
    • 23.4.2. Business Overview
    • 23.4.3. Business Segmentation by Revenue 2013
    • 23.4.4. Business Segmentation by Revenue 2011-2013
    • 23.4.5. Geographical Segmentation by Revenue 2013
    • 23.4.6. Business Strategy
    • 23.4.7. Recent Developments
    • 23.4.8. SWOT Analysis
  • 23.5. Sanofi SA
    • 23.5.1. Key Facts
    • 23.5.2. Business Description
    • 23.5.3. Business Segmentation
    • 23.5.4. Revenue by Business Segmentation
    • 23.5.5. Revenue Comparison 2012 and 2013
    • 23.5.6. Sales by Geography
    • 23.5.7. Business Strategy
    • 23.5.8. Key Developments
    • 23.5.9. SWOT Analysis

24. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Epinephrine Autoinjectors
  • Exhibit 4: Snapshot of Global Epinephrine Autoinjector Market 2014
  • Exhibit 5: Factors Influencing Development of Epinephrine Autoinjectors
  • Exhibit 6: Global Epinephrine Autoinjector Market 2014-2019 (US$ million)
  • Exhibit 7: Epinephrine Autoinjector Market in US 2014-2019 (US$ million)
  • Exhibit 8: Segmentation of Global Epinephrine Autoinjector Market by Geography 2014
  • Exhibit 9: Leading Brands in Global Epinephrine Autoinjectors Market
  • Exhibit 10: Design of EpiPen
  • Exhibit 11: EpiPen Administration Technique
  • Exhibit 12: Different Doses for Jext Autoinjector
  • Exhibit 13: Jext Administration Technique
  • Exhibit 14: Adrenaclick Administration Technique
  • Exhibit 15: Anapen Administration Technique
  • Exhibit 16: Auvi-Q Administration Technique
  • Exhibit 17: Leading Vendors in Global Epinephrine Autoinjector Market 2014
  • Exhibit 18: ALK-Abello: Total Revenue by Product Line 2014
  • Exhibit 19: ALK-Abello: Jext
  • Exhibit 20: Amedra Pharmaceuticals: Adrenaclick
  • Exhibit 21: Adrenaclick: Sales Revenue in US 2010-2013 (US$ million)
  • Exhibit 22: Lincoln Medical: Anapen
  • Exhibit 23: Mylan: EpiPen
  • Exhibit 24: EpiPen Autoinjector: Landscape
  • Exhibit 25: Sanofi: Key Facts and Figures 2014
  • Exhibit 26: Auvi-Q: Sales Revenue Q1-Q4 2014 (US$ million)
  • Exhibit 27: Sanofi: Auvi-Q
  • Exhibit 28: ALK-Abello: Product Segmentation by Revenue 2014
  • Exhibit 29: ALK-Abello: Product Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 30: ALK-Abello: Geographical Segmentation by Revenue 2014
  • Exhibit 31: Lincoln Medical : Geographical Presence
  • Exhibit 32: Global Epinephrine Autoinjector Market: Business Segmentation by Revenue 2013
  • Exhibit 33: Global Epinephrine Autoinjector Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 34: Global Epinephrine Autoinjector Market: Geographical Segmentation by Revenue 2013
  • Exhibit 35: Sanofi SA: Business Segmentation
  • Exhibit 36: Sanofi SA: Revenue by Business Segmentation 2013
  • Exhibit 37: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 38: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
Back to Top